Search results for "HPV"

showing 10 items of 166 documents

Detection of human papillomavirus DNA in formalin-fixed, paraffin-embedded squamous papillomas of the oral cavity

2018

Background Squamous papillomas are exophytic proliferations of surface oral epithelium. Human papillomavirus (HPV) infection is widely accepted as the etiology of squamous papillomas however the virus cannot be detected in a significant percentage of lesions. Material and methods Using polymerase chain reaction (PCR), we tested 35 formalin-fixed paraffin-embedded (FFPE) squamous papillomas for the presence of HPV DNA. Results Six papillomas (17%) tested positive for HPV DNA; four contained HPV-6 and two contained HPV-11. Given that β-globin DNA was only identified in half of the samples, DNA degradation appears to have significantly impacted the results. Conclusions The results likely repre…

0301 basic medicinePathologymedicine.medical_specialtyFormalin fixed paraffin embeddedOral cavityViruslaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelawHuman papillomavirus DNAmedicineGeneral DentistryPolymerase chain reactionOral Medicine and Pathologybusiness.industryResearchHPV infectionvirus diseases:CIENCIAS MÉDICAS [UNESCO]medicine.diseasefemale genital diseases and pregnancy complications030104 developmental biologychemistry030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASPapillomabusinessDNAJournal of Clinical and Experimental Dentistry
researchProduct

C3 Drives Inflammatory Skin Carcinogenesis Independently of C5

2021

Nonmelanoma skin cancer such as cutaneous squamous cell carcinoma (cSCC) is the most common form of cancer and can occur as a consequence of DNA damage to the epithelium by UVR or chemical carcinogens. There is growing evidence that the complement system is involved in cancer immune surveillance; however, its role in cSCC remains unclear. Here, we show that complement genes are expressed in tissue from patients with cSCC, and C3 activation fragments are present in cSCC biopsies, indicating complement activation. Using a range of complement-deficient mice in a two-stage mouse model of chemically-induced cSCC, where a subclinical dose of 7,12-dimethylbenz[a]anthracene causes oncogenic mutatio…

0301 basic medicineWT wild typeSkin NeoplasmsComplement receptorComplement Membrane Attack Complexmedicine.disease_causeBiochemistrychemistry.chemical_compoundMice0302 clinical medicineCR complement receptorComplement ActivationSkinMice KnockoutcSCC cutaneous squamous cell carcinomaComplement C5Complement C3Receptors Complement030220 oncology & carcinogenesisCarcinoma Squamous CellDisease ProgressionTumor BiologyOriginal ArticleMAC membrane attack complexSignal TransductionHPV16 human papillomavirus type 16910-Dimethyl-12-benzanthraceneTPA 12-O-tetradecanoylphorbol-13-acetateMice TransgenicDermatologySettore MED/08 - Anatomia Patologica03 medical and health sciencesmedicineAnimalsHumansC3Molecular BiologyReceptor Anaphylatoxin C5aDMBA 712-dimethylbenz[a]anthracenebusiness.industry712-Dimethylbenz[a]anthraceneCancerCell BiologyNeoplasms Experimentalmedicine.diseaseComplement systemDisease Models Animal030104 developmental biologychemistryTumor progressionCancer researchCarcinogensTumor EscapeSkin cancerbusinessCarcinogenesisComplement membrane attack complexSkin carcinogenesis.EC epithelial cell
researchProduct

HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory

2019

ABSTRACT HPV16 infections are associated with a variety of cancers and there is compelling evidence that the transforming activity of HPV16 critically depends on the expression of the viral oncoproteins E6 and E7. Therapeutic cancer vaccines capable of generating durable and specific immunity against these HPV16 antigens hold great promise to achieve long-term disease control. Here we show in mice that HPV16 E7 RNA-LPX, an intravenously administered cancer vaccine based on immuno-pharmacologically optimized antigen-encoding mRNA, efficiently primes and expands antigen-specific effector and memory CD8+ T cells. HPV-positive TC-1 and C3 tumors of immunized mice are heavily infiltrated with ac…

0301 basic medicinelcsh:Immunologic diseases. AllergyT cellImmunologyhpv16-positive malignancieslcsh:RC254-282t cell memoryhpv 16 rna-lpx03 medical and health sciences0302 clinical medicineImmune systemAntigenImmunology and AllergyCytotoxic T cellMedicineOriginal Researchbusiness.industryCancermedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens030104 developmental biologymedicine.anatomical_structureOncologyImmunization030220 oncology & carcinogenesisCancer researchCancer vaccinebusinesscancer vaccinelcsh:RC581-607CD8e7OncoImmunology
researchProduct

Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term obs…

2007

Abstract Background : Human papilloma virus (HPV) is one of the most frequently observed sexually transmitted infections. The study' purpose was to investigate the relation between a mother's gynecological history and the local status of her child with recurrent respiratory papillomatosis (RRP). Methods : Forty-two patients enrolled in a prospective multicenter study between 1983 and 1990. The study included patients with juvenile-onset and adult-onset RRP. All patients underwent surgery and treatment with α-interferon. Thirty-eight patients were followed up until 31.01.2006. Twenty-five mothers of these patients participated in a parallel prospective study of genital HPV infection. In 1989…

AdultCancer Researchmedicine.medical_specialtyAdolescentmedicine.medical_treatmentVaginal DiseasesPapillomatosisUterine Cervical DiseasesPregnancyRecurrenceRisk FactorsPrevalencemedicineHumansLongitudinal StudiesPregnancy Complications InfectiousChildProspective cohort studyReproductive HistoryAgedColposcopyGynecologyHysterectomyPapillomamedicine.diagnostic_testObstetricsbusiness.industryPapillomavirus InfectionsHPV infectionInfantMiddle AgedCondyloma AcuminatumHuman papillomavirus 6medicine.diseaseRespiratory Tract NeoplasmsKoilocyteOncologyChild PreschoolFemaleRecurrent Respiratory Papillomatosismedicine.symptombusinessCancer Detection and Prevention
researchProduct

Oral human papillomavirus infection in women with cervical HPV infection: new data from an Italian cohort and a metanalysis of the literature.

2011

Summary A key issue in oral HPV infection is whether it can be associated with a genital HPV infection, or whether it can be considered as an independent event. This analysis evaluated the frequency and type-concordance of oral HPV infection in women with cervical HPV infection by means of: (i) a cross-sectional study on a sample (n = 98) of Italian women; and (ii) a literature-based metanalysis, including the experimental study the subject of this Paper and nine other published studies (n = 1017), which also examined the influence of oral sampling procedure (oral brushing vs oral rinse) and HIV status on oral HPV detection. The prevalence of oral HPV infection in the Italian study was 14.3…

AdultCancer Researchmedicine.medical_specialtySexually transmitted infection MetanalysisHpv detectionUterine Cervical DiseasesHIV/HPV infectionSettore MED/28 - Malattie OdontostomatologicheInternal medicinemedicineHumansSex organOral hpvHuman papillomavirusGynecologybusiness.industryPapillomavirus InfectionsHPV infectionvirus diseasesmedicine.diseaseHead and neck squamous-cell carcinomaCross-Sectional StudiesOncologyItalyCohortFemaleCervical HPV infectionHiv statusOral SurgeryOral HPV infectionbusinessMouth DiseasesOral oncology
researchProduct

Peritoneal HPV‐DNA test in cervical cancer (PIONEER study): A proof of concept

2020

The aim of this study was to investigate the prevalence of peritoneal human papillomavirus (HPV) infection in different clinical cervical cancer (CC) settings, and its association with potential clinical and/or histological factors. This is a single-center, prospective, observational study. Consecutive patients with newly diagnosed or recurrent/persistent CC, between March 2019 and April 2020, were included. A group of patients undergoing surgery for benign gynecological conditions was included as control group. All patients underwent HPV-DNA test in the cervix and in the peritoneal cavity simultaneously at time of surgery. Two-hundred seventy-two patients had cervical and peritoneal HPV te…

AdultHPVCancer Researchmedicine.medical_specialtyMultivariate analysiscervical cancergenotypemedicine.medical_treatmentUterine Cervical Neoplasmsprognostic factors.GastroenterologyHuman Papillomavirus DNA Tests03 medical and health sciencesPeritoneal cavity0302 clinical medicinegenotypesInternal medicineGenotypemedicineHumansProspective StudiesStage (cooking)Peritoneal CavityCervixAgedNeoplasm StagingAged 80 and overCervical cancerHuman papillomavirus 16Human papillomavirus 18business.industryHPV infectionprognostic factorsMiddle Agedperitoneummedicine.diseaseCervical conizationinfectionSettore MED/40 - GINECOLOGIA E OSTETRICIAmedicine.anatomical_structureOncology030220 oncology & carcinogenesisFemalebusinessInternational Journal of Cancer
researchProduct

Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents

2016

Objective\ud To evaluate awareness of HPV and its vaccine among Latvian adolescents.\ud \ud Methods\ud A cross‐sectional survey was conducted in a 2‐week period in September 2015 among 270 adolescents attending a secondary school in Riga, Latvia. All students present during sexual‐health classes (grades 10–12 [aged 16–21 years]) were included. A self‐administered paper‐based survey assessed sociodemographic factors, sexual behaviours, smear history and knowledge of sexually transmitted infections, HPV and HPV vaccine knowledge, and sources of information.\ud \ud Results\ud Overall, 121 surveys were completed (62 by male students and 59 by female students). Latvian adolescents lacked awarene…

AdultHealth Knowledge Attitudes PracticeAdolescentPopulationUterine Cervical Neoplasms03 medical and health sciencesSexually active0302 clinical medicineRA0421Surveys and QuestionnairesPrevalenceHumansMedicinePapillomavirus Vaccines030212 general & internal medicineeducationFemale studentseducation.field_of_studyHigh prevalencebusiness.industryPapillomavirus InfectionsHPV infectionObstetrics and GynecologyLatvianHpv vaccinationGeneral MedicinePatient Acceptance of Health Caremedicine.diseaseLatviaR1female genital diseases and pregnancy complicationslanguage.human_languageVaccinationAdolescent Behavior030220 oncology & carcinogenesisImmunologylanguageWomen's HealthFemalebusinessDemographyInternational Journal of Gynecology & Obstetrics
researchProduct

HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy

2007

Human papillomavirus (HPV) infection is the commonest sexually transmitted infection, and high-risk HPV types are associated with cervical carcinogenesis. This study investigated: the HPV type-specific prevalence in 970 women with an abnormal cytological diagnosis; and the association of HPV infection and cervical disease in a subset of 626 women with a histological diagnosis. HPV-DNA was researched by nested PCR/sequencing and the INNOLiPA HPV Genotyping assay. The data were analysed by the chi-square test (p ? 0.05 significant). Overall, the HPV prevalence was 37.7%; high-risk genotypes were found in 88.5% of women and multiple-type infections in 30.9% of the HPV-positive women. The commo…

AdultHpv genotypesCancer Researchmedicine.medical_specialtyAdolescentGenotypeCervix UteriBiologyPolymerase Chain ReactionVirologyInternal medicineHistological diagnosisGenotypeEpidemiologyPrevalencedistributionmedicineHumanssamplesPapillomaviridaeHigh prevalenceHpv typesPapillomavirus InfectionscervicalHPV infectionvirus diseasesMiddle AgedUterine Cervical Dysplasiamedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaVirologyfemale genital diseases and pregnancy complicationsInfectious DiseasesItalyDNA ViralFemaleNested polymerase chain reactionVirus Research
researchProduct

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-lab…

2021

Abstract: Background: Efficacy of the nine-valent human papillomavirus (9vHPV; HPV types 6/11/16/18/31/33/45/52/58) vaccine was demonstrated in a phase 3 study in women 16 & ndash;26 years of age. We present a phase 3 immunogenicity and safety study of the 9vHPV vaccine in women 27 & ndash;45 versus 16 & ndash;26 years of age. Methods: This international, open-label study (NCT03158220) was conducted in women 16 & ndash;45 years of age. Participants (16 & ndash;26 years, n = 570 and 27 & ndash;45 years, n = 642) received a three-dose 9vHPV vaccination regimen (day 1, month 2, month 6). Month 7 geometric mean titers (GMTs) and seroconversion percentages to anti-HPV 6/11/16/18/31/33/45/52/58 w…

AdultHuman papillomavirusmedicine.medical_specialtyAdolescentAntibodies ViralYoung Adult03 medical and health sciencesNine-valent human papillomavirus vaccineImmunogenicity Vaccine0302 clinical medicine030225 pediatricsInternal medicinemedicineHumansPapillomavirus Vaccines030212 general & internal medicineSeroconversionHPV prophylaxisAdverse effectAgedCervical cancerHuman papillomavirus 16Human papillomavirus 18General VeterinaryGeneral Immunology and Microbiologybusiness.industryPapillomavirus InfectionsAdult vaccinationPublic Health Environmental and Occupational Healthmedicine.diseaseVaccine efficacyConfidence interval3. Good healthVaccinationClinical trialPrecancerRegimenInfectious DiseasesCervical cancerMolecular MedicineFemaleHuman medicinebusinessVaccine
researchProduct

HPV infection in semen: results from a new molecular approach

2019

AbstractHuman papillomavirus (HPV) is the agent of the most common sexually transmitted diseases causing a variety of clinical manifestations ranging from warts to cancer. Oncogenic HPV infection is the major cause of cervical cancer and less frequently of penile cancers. Its presence in semen is widely known, but the effects on fertility are still controversial. We developed a new approach to evaluate virus localisation in the different semen components. We analysed also the specific genotype localisation and viral DNA quantity by qPCR. Results show that HPV DNA can be identified in every fraction of semen: spermatozoa, somatic cells and seminal plasma. Different samples can contain the HP…

AdultMale0301 basic medicineSettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypesexually transmitted diseasesEpidemiologySemenSettore BIO/11 - Biologia MolecolareBiologyVirusmale infertilityMale infertilityYoung Adult03 medical and health sciences0302 clinical medicineSemenGenotypePrevalencemedicineHumansSettore BIO/06 - Anatomia Comparata E CitologiaPapillomaviridaesemen parametersCervical cancerOriginal Paper030219 obstetrics & reproductive medicinePapillomavirus InfectionsHPV infectionvirus diseasesCancersexually transmitted diseaseMiddle Agedsemen infectionmedicine.diseaseVirologySpermSettore MED/40 - Ginecologia E Ostetricia030104 developmental biologyInfectious DiseasesItalyDNA ViralHPV infectionsemen parameterviral infection
researchProduct